1,853 material Form 8-K filings that 1,500 companies we cover made with the SEC in September 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Quantumsphere Acquisition Corporation and two purchaser entities delivered notice on September 1, 2026 terminating their October 3, 2025 merger agreement with Omnivate Global Ltd. and SACH Pte. Ltd. The transactions contemplated by the agreement will not be consummated, and the parties have reserved all rights and remedies. The company says it intends to keep evaluating opportunities to complete an initial business combination.
Merger Agreement dated October 3, 2025 terminated under Section 13.2(a) by written notice dated September 1, 2026
Purchaser Parties had earlier sent SACH a notice on July 14, 2026 covering certain matters, followed by a thirty-day period to address them
Transactions will not be consummated; all rights and remedies are reserved
Company intends to continue evaluating opportunities to complete an initial business combination
PMV Pharma agreed on August 31, 2026 to sell 22,055,000 shares and pre-funded warrants for 19,900,000 shares, each sold with a warrant, at a combined price of $1.21 per share, with warrants for 41,955,000 shares in total. The company estimates net proceeds of about $47.0 million and expects the offering to close on September 2, 2026. The warrants' exercise price can reset after an FDA decision accepting the rezatapopt New Drug Application, which could increase the number of shares issuable and add dilution for existing shareholders.
Offering includes 22,055,000 shares and pre-funded warrants for 19,900,000 shares, plus accompanying warrants for 41,955,000 shares, at a combined price of $1.21
Gross proceeds expected to be about $50.8 million; estimated net proceeds about $47.0 million; closing expected September 2, 2026
Warrants have a $1.21 initial exercise price and a five-year term; exercise price resets to the greater of 33% of the initial price or a VWAP-based level after the FDA NDA acceptance announcement for rezatapopt
Company believes proceeds plus existing cash will fund operations and capital expenditures into the first quarter of 2028, excluding any underwriters' option exercise
Barfresh's chief financial officer, Lisa Roger, is retiring with a last day of September 1, 2026, and chief executive Riccardo Delle Coste will serve as interim CFO. The company also named Philip Meneses as Controller (principal accounting officer) effective August 28, 2026, and director Alexander H. Ware, who chaired the Audit Committee, will resign effective September 15, 2026.
CFO Lisa Roger's last day is September 1, 2026; CEO Riccardo Delle Coste will serve as interim CFO.
Philip Meneses appointed Controller effective August 28, 2026, with an annual base salary of $130,000, bonus eligibility of up to 15% of that amount, and 20,800 restricted stock units subject to vesting.
Director Alexander H. Ware gave notice on August 31, 2026 of his resignation effective September 15, 2026; he chaired the Audit Committee. The filing says the resignation was not due to a disagreement with the company.
Chan Heng Fai resigned as Chairman and Chief Executive Officer of HWH International Inc. effective September 1, 2026, and will remain a director. Liu Ming Hui becomes Chairman and Liu Ming Xing becomes CEO; both are brothers tied to majority stockholder Smart Dynamics Technology Limited, which bought shares and warrants from the company on August 10, 2026. The filing names HWH International Inc. (Nasdaq: HWH), not EnerSyn Global Inc., so the company identity in the request should be checked.
Chan Heng Fai, 81, resigned as Chairman and CEO on September 1, 2026, and continues as a board member.
Liu Ming Hui was appointed Chairman (press release says Executive Chairman); Liu Ming Xing was appointed CEO.
Liu Ming Hui and Liu Ming Xing are brothers; Liu Ming Hui owns Smart Dynamics, the majority stockholder.
On August 10, 2026, Smart Dynamics bought 20,000,000 common shares and warrants for up to 160,000,000 shares for $10,000,000 under a securities purchase agreement amended June 8, 2026.
IP Strategy Holdings received a Nasdaq notice on August 26, 2026, because it has not yet filed its quarterly report for the period ended June 30, 2026, which breaches Nasdaq Listing Rule 5250(c)(1). The notice has no immediate effect on the stock's listing, but the company's common stock could face delisting if it does not regain compliance in time. The company says it intends to take the steps needed to regain compliance in September 2026.
Nasdaq letter dated August 26, 2026 cites late Form 10-Q for the period ended June 30, 2026
Company has until October 26, 2026 to submit a compliance plan to Nasdaq
If Nasdaq accepts the plan, the compliance deadline could be as late as February 22, 2027
Company says it intends to regain compliance in September 2026
Ryman Hospitality Properties completed its purchase of the JW Marriott Orlando Grande Lakes Resort and The Ritz-Carlton Orlando, Grande Lakes on September 1, 2026, for approximately $1.38 billion. The company also revised its 2026 guidance to include the property, raising its adjusted EBITDAre midpoint while lowering its per-share earnings midpoint.
Purchase price of approximately $1.38 billion was funded by a 5,865,000-share stock offering at $117.00 per share (closed August 12, 2026), $700 million of 6.250% senior notes due 2035 (closed August 25, 2026), and cash on hand.
Full-year 2026 consolidated Adjusted EBITDAre guidance midpoint rose to $926.5 million from $894.0 million; Grande Lakes Orlando contributes a $32.5 million midpoint.
Net income available to common stockholders per diluted share guidance midpoint fell to $3.93 from $4.11; Adjusted FFO per diluted share midpoint fell to $9.08 from $9.13.
The company does not expect to update guidance before its next quarterly earnings release.
Hornbeck Offshore completed mergers with Legacy Hornbeck, as shown by new Jones Act warrant agreements dated September 1, 2026, and a reconstituted board with William L. Transier as chairman. The filing also shows the termination of a $120 million Helix credit facility with no outstanding borrowings, an increase in revolving commitments to $125 million, and the departure of the chief executive, chief financial officer and general counsel.
Company issued 37,818,435 shares of common stock to consenting Legacy Hornbeck stockholders and assumed 8,617,903 Jones Act Warrants.
Helix terminated its $120 million asset-based credit facility with Bank of America; there were no outstanding borrowings.
First Incremental Facility Amendment raises revolving commitments to $125 million from $75 million, with $175 million of uncommitted incremental capacity.
Owen Kratz (CEO), Erik Staffeldt (CFO) and Ken Neikirk (general counsel) no longer hold their roles as of the Effective Time; Transier was appointed chairman.
Intellinetics CEO Matthew Chretien notified the company on August 26, 2026, that he will retire and resign as Secretary and Chief Strategy Officer, effective September 1, 2026. The company expects to enter a separation agreement with him, but the material terms have not been determined and will be disclosed later if required.
Matthew Chretien notified the company on August 26, 2026, of his retirement.
His resignations as Secretary and Chief Strategy Officer take effect September 1, 2026.
A separation agreement is expected, but its material terms have not been determined.
The 8-K is signed by Alison Forsythe, President and Chief Executive Officer, and dated September 1, 2026.
Yum! Brands completed the sale of its global Pizza Hut business, excluding mainland China, to Toppings TopCo, LLC (identified in the press release as LongRange Capital) on September 1, 2026, for $1,488,000,000 in cash, subject to adjustments. Pizza Hut China was sold separately to Yum China Holdings, Inc., which closed on August 7, 2026, bringing the two transactions to $2.7 billion in aggregate. Pizza Hut CEO Aaron Powell resigned from all Company positions effective the same day.
Pizza Hut ex-China sold for approximately $1.5 billion in cash, plus a possible earn-out of $75 million by 2030 tied to future performance
Pizza Hut China sale to Yum China Holdings, Inc. closed August 7, 2026; combined sale value $2.7 billion
Aaron Powell resigned as Pizza Hut CEO and from all other Company positions effective September 1, 2026
Chris Turner, Chief Executive Officer of Yum! Brands, describes the company as now more focused
Korn Ferry completed its acquisition of AMS, a UK-headquartered talent and organizational consulting firm, on September 1, 2026. The company paid about £473 million and $326 million in cash and issued 3,118,628 shares of common stock to the sellers, and the combined firm now has nearly 17,000 colleagues in more than 130 offices. Shareholders will see the share issuance and cash outlay, and the financial statements and pro forma information for the deal have not yet been filed.
Acquisition closed September 1, 2026; AMS is now an indirect wholly owned subsidiary of Korn Ferry
Cash paid: about £473 million and $326 million, covering seller proceeds, AMS debt repayment and other obligations
Issued 3,118,628 shares of Korn Ferry common stock to the sellers, exempt from registration under Section 4(a)(2)
Financial statements and pro forma information will be filed by amendment within 71 calendar days
Albany International said it completed its strategic review of the Amelia Earhart Drive facility in Salt Lake City and will keep the site, following an amended CH-53K contract with Sikorsky and new business wins. The company also reversed part of a forward loss reserve from the third quarter of 2025 and raised its third-quarter 2026 adjusted EPS outlook to $1.40 to $1.50, while its net revenue outlook was unchanged.
The company will retain the Amelia Earhart Drive facility and end the strategic review; Guggenheim Securities served as its financial advisor.
It reversed a portion of the forward loss reserve recognized in Q3 2025 on the CH-53K contract, and the contract modification is expected to generate positive cash flow beginning in 2027.
Q3 2026 adjusted EPS outlook rose from $0.60 to $0.70 to $1.40 to $1.50; Q3 consolidated net revenue outlook remains $320 million to $330 million.
Q4 2026 outlook calls for consolidated net revenue of $325 million to $335 million and adjusted EPS of $0.65 to $0.75; investor webcast on September 2, 2026 at 8:30 a.m. ET.
Moderna completed a private offering of $3.0 billion in 0.00% convertible senior notes due March 1, 2032, including the full exercise of a $400 million option for additional notes. The notes carry no regular interest, and the company expects about $285.0 million of net proceeds to go toward the cost of capped call transactions, with the rest for general corporate purposes, which may include oncology growth and debt repayment.
Offering size: $3.0 billion aggregate principal, including $400 million from the initial purchasers' option, completed September 1, 2026
Initial conversion price of about $210.58 per share, a 47.5% premium over the $142.77 closing price on August 27, 2026
Capped call transactions cost approximately $285.0 million; estimated net proceeds are about $2,957.3 million including the option
Notes may not be redeemed before September 6, 2029, except in a cleanup redemption
Palo Alto Networks reported fiscal fourth-quarter 2026 revenue of $3.41 billion, up 34% year over year, and non-GAAP net income per diluted share of $1.02, up from $0.95. The company posted a GAAP net loss of $282 million, or $0.35 per diluted share, compared with GAAP net income of $254 million, or $0.36, a year earlier, and it also announced the acquisition of Console and fiscal 2027 guidance for revenue of $14.10 billion to $14.20 billion.
Q4 fiscal 2026 revenue $3.41 billion, up 34% year over year; Next-Generation Security ARR $9.10 billion, up 63%
GAAP net loss $282 million, or ($0.35) per diluted share, versus GAAP net income of $254 million a year earlier; the filing lists a $524 million change in fair value of convertible senior notes and capped calls among non-GAAP adjustments
Non-GAAP operating income $1.0 billion versus $768 million a year earlier; adjusted free cash flow $1.3 billion
Fiscal 2027 guidance: total revenue $14.10 billion to $14.20 billion; diluted non-GAAP EPS $4.16 to $4.19; first-quarter revenue $3.300 billion to $3.310 billion
Vertex Pharmaceuticals appointed Jonathan Poole as Executive Vice President and Chief Financial Officer on August 27, 2026, effective January 1, 2027. Charles F. Wagner, Jr. will stop serving as CFO on that date but will remain Executive Vice President and Chief Operating Officer. The filing discloses Mr. Poole's salary, bonus target and severance terms, which shareholders may review in the 10-Q exhibits later.
Jonathan Poole, 51, becomes EVP and CFO effective January 1, 2027, having been Senior Vice President, Finance at Vertex since March 2020
Charles F. Wagner, Jr. ceases to be CFO on the effective date and remains EVP and Chief Operating Officer
Poole's base salary is $750,000, with a target annual bonus of 90% of base salary
Severance on termination without cause or for good reason is 100% of base salary and target bonus; the change of control agreement covers the period from 90 days before to 12 months after a change of control
Calumet's subsidiary Montana Renewables amended its loan guarantee agreement with the U.S. Department of Energy on August 28, 2026, reducing the maximum loan principal to $815.8 million from $1.44 billion as the Great Falls expansion shifts to repurposing existing equipment. The company says remaining expansion capital is $137 million, to be funded from Montana Renewables earnings with no third-party equity, and targets about 200 million gallons of annual SAF production by year-end 2028. Lower capital needs and no dilution stand against a smaller project, which the company says captures about 70% of the originally expected benefit.
Maximum DOE loan principal reduced to $815.8 million and capitalized interest cap to $232.8 million.
Remaining expansion capital is $137 million, versus the $1.2 billion original Phase 2 plan.
Phase 2 DOE funding cut from up to $658 million to a single final draw of $34 million.
Target of about 200 million gallons of annual SAF production and 17,000 barrels per day of total product sales by year-end 2028.
GitLab reported second-quarter fiscal 2027 revenue of $286.3 million, up 21% from a year earlier, while its GAAP net loss widened to $36.8 million from $9.2 million. The company also said Chief Accounting Officer Simon Mundy will resign effective September 16, 2026, and CFO Jessica Ross will take on the principal accounting officer role.
Revenue of $286.3 million, up 21% year over year; non-GAAP operating income of $42.6 million, versus $39.6 million a year earlier
GAAP net loss attributable to GitLab of $36.8 million, or $(0.22) per share, compared with a loss of $9.2 million, or $(0.06) per share, a year earlier
Restructuring charges of $19.4 million were excluded from non-GAAP results; the restructuring was announced in May 2026
Third-quarter revenue guidance of $281 million to $283 million; fiscal 2027 revenue guidance of $1,129 million to $1,133 million
Mohawk Industries said on September 1, 2026 that An Nuyttens, a former Solvay executive, will become president of its Flooring Rest of the World segment effective mid-October, succeeding Paul De Cock, who has led the segment on an interim basis. The filing also says De Cock becomes chief executive officer effective September 30, 2026. The filing contains no financial results or guidance.
Nuyttens has more than 30 years of international leadership experience at Solvay, including senior executive roles in Europe and the United States.
Nuyttens takes over the segment effective mid-October 2026, replacing De Cock as interim leader.
Paul De Cock, Chief Operating Officer, becomes Chief Executive Officer effective September 30, 2026.
The segment serves customers in Europe, Asia-Pacific, Latin America and other international markets, including the Unilin business.
Dell reported fiscal second-quarter 2027 results for the quarter ended July 31, 2026, with net revenue of $46,971 million, up 58% year over year, and diluted EPS of $6.34, up 273%. Dell raised its full-year FY27 revenue guidance to $192.0 billion from $167.0 billion and its GAAP diluted EPS guidance to $24.37 from $17.31, while cash flow from operations fell 13% in the quarter to $2.2 billion.
Q2 net revenue of $47.0 billion, up 58% year over year; GAAP diluted EPS of $6.34, up 273%
Full-year FY27 revenue guidance raised to $192.0 billion from $167.0 billion; GAAP diluted EPS guidance $24.37, up from $17.31
Q3 FY27 guidance: revenue of $49.0 billion and GAAP diluted EPS of $6.10
Record $4.3 billion returned to shareholders in Q2; quarterly dividend of $0.63 per share payable Oct. 30 to holders of record as of Oct. 20
Root, Inc. entered into agreements with Carvana on August 31, 2026, cancelling Carvana's long-term warrants issued October 1, 2021, and issuing a new warrant for up to 1,525,560 Class A shares, exercisable only if conditions tied to insurance sales through the Integrated Platform are met. The filing also amends the commercial agreement, investment agreement and registration rights agreement between the companies, including changes to term, non-renewal notice and exclusivity.
Carvana surrendered and Root cancelled all outstanding long-term warrants issued October 1, 2021
New warrant covers up to 1,525,560 Class A common shares, split into five tranches of 305,112 shares each
Each tranche is subject to conditions, including milestones tied to insurance sales through the Integrated Platform
Second Amendment to the Commercial Agreement changes term, non-renewal notice and exclusivity terms
Shuttle Pharmaceuticals Holdings signed a First Amendment to its April 30, 2026 Merger Agreement with its subsidiary United Dogecoin, lowering the Mining Rigs number in the Milestone Event from 2,000 to 500. The company says the cap on pre-funded warrants and shares issuable does not change, and it is seeking similar amendments to its PIPE Financing and Second Amendment to the Asset Purchase Agreement, which requires approval from investors and other parties.
Amendment dated August 31, 2026 reduces the Mining Rigs threshold in the Milestone Event from 2,000 to 500.
No other Merger Agreement terms were changed; the maximum number of pre-funded warrants issuable is unchanged.
The company is seeking parallel amendments to the Securities Purchase Agreement (1,910 shares of Series B-2 preferred stock, PIPE Financing closed May 6, 2026) and the Second Amendment to the Asset Purchase Agreement, which requires approva
Park Dental Partners said it identified unauthorized access to its computer network on August 28, 2026, and is investigating whether personal or protected health information was compromised. The company says the incident has not materially disrupted operations and has not identified any material impact on its financial condition, but it cannot yet estimate the financial, legal, operational or reputational impact.
Unauthorized network access identified on August 28, 2026; external cybersecurity and forensic specialists engaged
Company is treating the incident as a reportable event due to possible access to patient data
No material impact identified on financial condition, results of operations or business operations; an impact estimate is not yet reasonably possible
Investigation is ongoing and the assessment could change as more information becomes available
Sprouts Farmers Market said its board appointed President and Chief Operating Officer Nick Konat as chief executive and a director, effective January 4, 2027, the first day of its 2027 fiscal year. Jack Sinclair, CEO since June 2019, will become executive chairman at that time. The filing does not include financial results or guidance tied to the change.
Nick Konat, age 49, has been president and chief operating officer since March 2022 and previously held roles at Petco and Target.
Konat's annual base salary will rise to $1,000,000 on January 4, 2027, with a target bonus of 125% of salary and long-term equity incentive opportunity of 600% of salary.
Jack Sinclair becomes executive chairman with a $900,000 base salary, a 100% target bonus and a 333% long-term equity incentive opportunity.
The board will expand to nine members, and Chairman Joseph Fortunato will serve as lead independent director from the same date.
Kustom Entertainment signed a Unit Purchase Agreement on August 31, 2026, to acquire all equity interests of TFL, LLC for $89.6 million in cash and $22.4 million in restricted common stock, with an additional $11.2 million in stock held back and tied to TFL's Target EBITDA through 2027. Closing requires conditions including third-party consents, stockholder approvals and sufficient funds, and either party may terminate if the deal is not completed by October 15, 2026. Shareholders would see new restricted shares issued and a seller-designated director join the board at closing.
Cash consideration of $89.6 million, subject to adjustments based mainly on TFL's closing net debt and transaction expenses
Stock consideration of $22.4 million in restricted common stock, priced on the 10-day volume weighted average trading price before closing
$11.2 million holdback in restricted shares, issued only if a specified Target EBITDA is achieved from closing through calendar year 2027
Company will repay $35.0 million of TFL indebtedness at closing; the agreement's outside date is October 15, 2026
Snail, Inc. said the Nasdaq Hearings Panel granted its request to continue listing Class A Common Stock on the Nasdaq Capital Market, subject to meeting a $2,500,000 minimum stockholders' equity requirement. The company must also file public disclosure of the transactions it undertakes to comply and the resulting equity, and the company says failure to meet the conditions would result in delisting.
Panel decision received August 26, 2026; the stock will keep trading as SNAL during the exception period.
Company must reach minimum stockholders' equity of $2,500,000 under Nasdaq Listing Rule 5550(b) and file public disclosure of its compliance steps.
Company regained compliance with the $1.00 minimum bid price after a reverse stock split effective July 2, 2026; Nasdaq Staff confirmed on July 21, 2026.
The Panel may reconsider the exception based on significant events, and failure to meet the conditions would result in delisting.
Idaho Copper reported on its fiscal second quarter ended July 31, 2026, citing its July 2, 2026 move to the NYSE American and an underwritten offering with approximately $18.0 million in gross proceeds. The company said it had about $12.1 million of cash on hand and expects to release an updated Preliminary Economic Assessment for its CuMo project in the near term. The filing reports no revenue, profit, or guidance figures, so the financial effect on shareholders is not quantified.
Common stock and publicly traded warrants began trading on the NYSE American on July 2, 2026 under COPR and COPR WS
Underwritten public offering with aggregate gross proceeds of approximately $18.0 million
Approximately $12.1 million of cash on hand, per CEO Andrew Brodkey
Bruce Harmon appointed Chief Financial Officer; updated PEA expected in the near term and will supersede the 2020 PEA
Alumis said its Phase 2b LUMUS trial of envudeucitinib in systemic lupus erythematosus did not meet its primary or secondary endpoints in the overall population of 408 patients. The company highlighted a prespecified subgroup with high interferon gene signature, where responses were robust, and plans to engage regulators on Phase 3 development, while its planned NDA for psoriasis remains on track for the fourth quarter of 2026.
LUMUS enrolled 408 patients; the primary endpoint, BICLA at Week 48, was not met in the overall trial population.
In the prespecified IFNGS-high subgroup, BICLA response was 52.6% on 40mg twice-daily versus 28.6% on placebo.
Alumis plans an end-of-Phase 2 meeting with the FDA and EMA to discuss Phase 3 development in SLE.
The NDA for envudeucitinib in moderate-to-severe plaque psoriasis remains planned for the fourth quarter of 2026.
Chesapeake Utilities' subsidiary Peninsula Pipeline Holdings sold a 49% interest in the Florida Energy Pathway project to a unit of NextEra Energy Resources, and Peninsula keeps the remaining 51%. The project is estimated at about $1.2 billion in total investment, so the partner will share construction and funding obligations, while Chesapeake's parent guaranty of about $109 million backs its share of capital contributions.
NextEra unit FEP Pipeline Holdings, LLC acquired a 49% membership interest; Peninsula retains 51%, under an LLC agreement dated August 28, 2026, effective September 1, 2026.
Total project investment is estimated at approximately $1.2 billion, pending finalization of design and development activities.
Chesapeake's guaranty for Peninsula's capital contribution obligations is initially approximately $109 million.
Construction is expected to begin in the first half of 2028, with the project anticipated to be in service in 2030.
Fervo Energy's subsidiary Cape Generating Station 6 LLC signed a 15-year power purchase agreement with Google for 396 MW from the Cape Station project in Utah, with target commercial operation beginning in the third quarter of 2028. Fervo also agreed to offer Google an option on about 600 MW more capacity, with a guaranteed commercial operation date no later than June 2030, and must reimburse Google for certain amounts if it does not make that offer, an amount the company says is not currently estimable. For shareholders, this adds a large contracted customer, but it also brings an unquantified contingent obligation and depends on Utah regulatory approvals.
Power purchase agreement with Google Energy LLC, a subsidiary of Alphabet Inc., dated August 26, 2026, for 396 MW in four 99 MW sub-tranches
Target commercial operation for sub-tranches begins in the third quarter of 2028; 15-year delivery term
Capacity expansion option of about 600 MW, bringing total contracted capacity to not less than about 950 MW, with guaranteed commercial operation by June 2030
Reimbursement obligation if the expansion offer is not made is not currently estimable; project remains subject to Utah SB 132 regulatory approvals
Figure Technology Solutions completed its previously announced acquisition of Kiavi, Inc. on September 1, 2026, paying approximately $590 million in cash, net of cash acquired, for Kiavi's technology platform and DSCR loans. The company said it primarily funded the deal with net proceeds from $600 million of 8.500% Senior Notes due 2031, and it repaid Kiavi's credit facility and terminated a related repurchase agreement at closing.
Cash consideration of approximately $590 million, net of cash acquired, subject to customary adjustments
Primarily funded by $600 million of 8.500% Senior Notes due 2031, which closed July 14, 2026
Kiavi's credit agreement and Deutsche Bank master repurchase agreement repaid or terminated at closing
Merger agreement was dated June 10, 2026; integration and synergy realization are listed as risks
Invivyd, Inc. appointed Chairman Marc Elia as Chief Executive Officer effective August 30, 2026, taking over as principal executive officer from William Duke, Jr., who remains Chief Financial Officer. The company also added Ian Sheffield to its board and named Ajay Royan Lead Independent Director, and the company said VYD2311 top-line data is still expected around the end of Q3 2026.
Marc Elia, Chairman since July 2022, became CEO effective August 30, 2026, and will also remain Chairman.
Elia's employment agreement provides a $750,000 base salary, a 70% target bonus, a $500,000 sign-on bonus, and an option to buy 10,700,000 shares.
Ian Sheffield was appointed a director on August 30, 2026, and Ajay Royan was named Lead Independent Director.
Invivyd expects top-line data from the VYD2311 program around the end of Q3 2026.
MiniMed reported first-quarter fiscal 2027 net sales of $843 million, up 16.6% from $723 million a year earlier, and reported net income of $0 compared with a loss of $16 million. The company raised its fiscal 2027 organic revenue growth guidance to approximately 10.5% from approximately 10%, while reaffirming its adjusted EBITDA margin guidance of approximately 16%.
Net sales were $843 million vs. $723 million; U.S. net sales grew 13.1% to $240 million and international grew 18.1% to $603 million.
Net income attributable to the company was $0 (EPS $0.00) vs. a loss of $19 million (EPS -$0.08) a year earlier.
FY27 organic revenue growth guidance raised to approximately 10.5% from approximately 10%; the figure includes a 1.0% to 1.5% benefit from an extra week in Q1.
Adjusted EBITDA margin guidance of approximately 16% was reaffirmed; a $2 million litigation benefit was recorded vs. a $17 million charge a year earlier.
Medtronic reported first quarter fiscal 2027 revenue of $9.8 billion, up 13.7% as reported and organically, and GAAP diluted EPS of $1.14 versus $0.81 a year earlier. The company raised its fiscal 2027 organic revenue growth guidance to 7.25% to 7.75% and its non-GAAP diluted EPS guidance to $5.94 to $6.00, both measures improving on the prior outlook.
Q1 revenue of $9.756 billion, up 13.7% as reported and organically; the extra fiscal week benefited organic growth by approximately $570 million, per the company
Q1 GAAP diluted EPS of $1.14, up 40.7%; non-GAAP diluted EPS of $1.45, up 15.1%
FY27 organic revenue growth guidance raised to 7.25% to 7.75% from 6.75% to 7.25%
FY27 non-GAAP diluted EPS guidance raised to $5.94 to $6.00 from $5.90 to $6.00
AptarGroup expanded its board from ten to eleven directors and appointed Gael Touya as a director effective September 1, 2026. Touya also became President and Chief Executive Officer that day, succeeding Stephan B. Tanda, who retired; the CEO change was previously disclosed in a March 17, 2026 filing. For shareholders, this filing confirms the leadership transition and board addition, with no financial results or guidance included.
Gael Touya appointed director effective September 1, 2026, with term expiring at the 2028 annual meeting.
Board size increased from ten to eleven directors on August 29, 2026.
Touya, formerly President of the Aptar Pharma segment, became CEO on September 1, 2026, succeeding Stephan B. Tanda.
Touya will not receive additional pay for board service; CEO compensation was disclosed in the March 17, 2026 8-K.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.